Interleukin 12 at the site of disease in tuberculosis.

PubWeight™: 1.98‹?› | Rank: Top 2%

🔗 View Article (PMC 294229)

Published in J Clin Invest on April 01, 1994

Authors

M Zhang1, M K Gately, E Wang, J Gong, S F Wolf, S Lu, R L Modlin, P F Barnes

Author Affiliations

1: Department of Medicine, University of Southern California School of Medicine, Los Angeles 90033.

Articles citing this

Multiple control elements mediate activation of the murine and human interleukin 12 p40 promoters: evidence of functional synergy between C/EBP and Rel proteins. Mol Cell Biol (1997) 3.70

Innate immunity to Mycobacterium tuberculosis. Clin Microbiol Rev (2002) 2.79

Inhibition of IL-12 production by 1,25-dihydroxyvitamin D3. Involvement of NF-kappaB downregulation in transcriptional repression of the p40 gene. J Clin Invest (1998) 2.78

T-cell cytokine responses in human infection with Mycobacterium tuberculosis. Infect Immun (1995) 2.57

Immunopathology of tuberculosis: roles of macrophages and monocytes. Infect Immun (1996) 2.41

Induction of gamma interferon production in human alveolar macrophages by Mycobacterium tuberculosis. Infect Immun (1997) 2.16

Beta2-agonists prevent Th1 development by selective inhibition of interleukin 12. J Clin Invest (1997) 1.94

Interleukin-10 downregulates Mycobacterium tuberculosis-induced Th1 responses and CTLA-4 expression. Infect Immun (1996) 1.85

Interleukin-12 production by human monocytes infected with Mycobacterium tuberculosis: role of phagocytosis. Infect Immun (1996) 1.77

Bacterial superantigens induce T cell expression of the skin-selective homing receptor, the cutaneous lymphocyte-associated antigen, via stimulation of interleukin 12 production. J Exp Med (1995) 1.65

Interleukin-12 in infectious diseases. Clin Microbiol Rev (1997) 1.63

Interleukin-12 induction of Th1 cytokines is important for viral clearance in chronic hepatitis B. J Clin Invest (1997) 1.62

Chemokine production by a human alveolar epithelial cell line in response to Mycobacterium tuberculosis. Infect Immun (1998) 1.58

Absence of a prominent Th2 cytokine response in human tuberculosis. Infect Immun (1996) 1.51

Production of monocyte chemoattractant protein 1 in tuberculosis patients. Infect Immun (1998) 1.29

Evidence for a predominant proinflammatory conjunctival cytokine response in individuals with trachoma. Infect Immun (1996) 1.23

Evidence inconsistent with a negative influence of T helper 2 cells on protection afforded by a dominant T helper 1 response against Mycobacterium tuberculosis lung infection in mice. Infect Immun (2002) 1.19

T lymphocyte phenotypic profile in lung segments affected by cavitary and non-cavitary tuberculosis. Clin Exp Immunol (2003) 1.19

Depressed interleukin-12 (IL-12), but not IL-18, production in response to a 30- or 32-kilodalton mycobacterial antigen in patients with active pulmonary tuberculosis. Infect Immun (2000) 1.13

Brucella abortus as a potential vaccine candidate: induction of interleukin-12 secretion and enhanced B7.1 and B7.2 and intercellular adhesion molecule 1 surface expression in elutriated human monocytes stimulated by heat-inactivated B. abortus. Infect Immun (1996) 1.10

Interleukin-12-stimulated natural killer cells can activate human macrophages to inhibit growth of Mycobacterium avium. Infect Immun (1995) 1.06

Depressed CD40 ligand expression contributes to reduced gamma interferon production in human tuberculosis. Infect Immun (2000) 1.04

Bovine tuberculosis: immune responses in the peripheral blood and at the site of active disease. Immunology (2000) 1.04

Mycobacterium tuberculosis-induced gamma interferon production by natural killer cells requires cross talk with antigen-presenting cells involving Toll-like receptors 2 and 4 and the mannose receptor in tuberculous pleurisy. Infect Immun (2007) 0.99

Naive human T cells develop into Th1 effectors after stimulation with Mycobacterium tuberculosis-infected macrophages or recombinant Ag85 proteins. Infect Immun (2000) 0.92

Compartmentalized bronchoalveolar IFN-gamma and IL-12 response in human pulmonary tuberculosis. Tuberculosis (Edinb) (2008) 0.92

Tailored immune responses: novel effector helper T cell subsets in protective immunity. PLoS Pathog (2014) 0.92

Increased circulating interleukin-12 (IL-12) p40 in pulmonary sarcoidosis. Clin Exp Immunol (2003) 0.91

CD4(+) CD25(high) forkhead box protein 3(+) regulatory T lymphocytes suppress interferon-γ and CD107 expression in CD4(+) and CD8(+) T cells from tuberculous pleural effusions. Clin Exp Immunol (2014) 0.91

IL-12 as a therapeutic target for pharmacological modulation in immune-mediated and inflammatory diseases: regulation of T helper 1/T helper 2 responses. Br J Pharmacol (1999) 0.91

Increased numbers of interleukin-12-producing cells in human tuberculosis. Infect Immun (1996) 0.90

Interleukin-12 gene expression in human monocyte-derived macrophages stimulated with Mycobacterium bovis BCG: cytokine regulation and effect of NK cells. Infect Immun (1997) 0.89

Protection of mice from Mycobacterium avium infection by recombinant interleukin-12. Antimicrob Agents Chemother (1995) 0.89

Pattern recognition receptors and cytokines in Mycobacterium tuberculosis infection--the double-edged sword? Biomed Res Int (2013) 0.87

Phosphorylation of mitogen-activated protein kinases contributes to interferon γ production in response to Mycobacterium tuberculosis. J Infect Dis (2012) 0.81

Selective T-cell recognition of the N-terminal peptide of GroES in tuberculosis. Infect Immun (2002) 0.81

Novel 33-kilodalton lipoprotein from Mycobacterium leprae. Infect Immun (2002) 0.81

In vitro levels of interleukin 10 (IL-10) and IL-12 in response to a recombinant 32-kilodalton antigen of Mycobacterium bovis BCG after treatment for tuberculosis. Clin Vaccine Immunol (2008) 0.80

Morphine withdrawal stress modulates lipopolysaccharide-induced interleukin 12 p40 (IL-12p40) expression by activating extracellular signal-regulated kinase 1/2, which is further potentiated by glucocorticoids. J Biol Chem (2011) 0.80

Increased pleural soluble fas ligand (sFasL) levels in tuberculosis pleurisy and its relation with T-helper type 1 cytokines. Lung (2008) 0.78

IL12B expression is sustained by a heterogenous population of myeloid lineages during tuberculosis. Tuberculosis (Edinb) (2013) 0.77

Flow cytometry--a rapid tool to correlate functional activities of human peripheral blood lymphocytes with their corresponding phenotypes after in vitro stimulation. BMC Immunol (2002) 0.77

Interleukin-12: potential clinical applications in the treatment and prevention of infectious diseases. Drugs (1996) 0.76

Cytokines and Chemokines in Mycobacterium tuberculosis Infection. Microbiol Spectr (2016) 0.75

IL12Rβ1ΔTM is a secreted product of il12rb1 that promotes control of extrapulmonary tuberculosis. Infect Immun (2014) 0.75

Angiogenic activity of sera from pulmonary tuberculosis patients in relation to IL-12p40 and TNFα serum levels. Lung (2011) 0.75

Articles cited by this

Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. Science (1993) 19.80

The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection. Cell (1989) 10.98

Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J Exp Med (1989) 10.60

Defining protective responses to pathogens: cytokine profiles in leprosy lesions. Science (1991) 8.85

Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells. J Exp Med (1993) 8.76

Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells. J Exp Med (1992) 8.27

Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J Exp Med (1993) 8.03

Interleukin 12 and tumor necrosis factor alpha are costimulators of interferon gamma production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist. Proc Natl Acad Sci U S A (1993) 6.33

Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells. J Immunol (1991) 6.30

Recombinant interleukin 12 cures mice infected with Leishmania major. J Exp Med (1993) 5.75

Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response. J Exp Med (1993) 5.71

Interleukin-12 and its role in the generation of TH1 cells. Immunol Today (1993) 5.55

T lymphocytes mediating protection and cellular cytolysis during the course of Mycobacterium tuberculosis infection. Evidence for different kinetics and recognition of a wide spectrum of protein antigens. J Immunol (1992) 5.00

Tumor necrosis factor is involved in the T cell-independent pathway of macrophage activation in scid mice. J Immunol (1989) 4.70

Induction of TH1 and TH2 responses: a key role for the 'natural' immune response? Immunol Today (1992) 4.63

Purification to homogeneity and partial characterization of cytotoxic lymphocyte maturation factor from human B-lymphoblastoid cells. Proc Natl Acad Sci U S A (1990) 4.60

Gamma interferon activates human macrophages to become tumoricidal and leishmanicidal but enhances replication of macrophage-associated mycobacteria. Infect Immun (1985) 4.56

Coexpression of two distinct genes is required to generate secreted bioactive cytotoxic lymphocyte maturation factor. Proc Natl Acad Sci U S A (1991) 4.48

Tumor necrosis factor, alone or in combination with IL-2, but not IFN-gamma, is associated with macrophage killing of Mycobacterium avium complex. J Immunol (1988) 4.47

CD8+ T lymphocytes in intracellular microbial infections. Immunol Today (1988) 4.12

Local and systemic effects of intradermal recombinant interferon-gamma in patients with lepromatous leprosy. N Engl J Med (1986) 4.05

Local production of tumor necrosis factor and IFN-gamma in tuberculous pleuritis. J Immunol (1990) 3.85

Regulation of human lymphocyte proliferation by a heterodimeric cytokine, IL-12 (cytotoxic lymphocyte maturation factor). J Immunol (1991) 3.40

Natural killer (NK) cell stimulatory factor or IL-12 has differential effects on the proliferation of TCR-alpha beta+, TCR-gamma delta+ T lymphocytes, and NK cells. J Immunol (1992) 3.15

Cytokine production at the site of disease in human tuberculosis. Infect Immun (1993) 3.04

Cytokine production induced by Mycobacterium tuberculosis lipoarabinomannan. Relationship to chemical structure. J Immunol (1992) 3.03

Spleen cell cytokine secretion in Mycobacterium bovis BCG-infected mice. Infect Immun (1992) 2.50

Regulation of human cytolytic lymphocyte responses by interleukin-12. Cell Immunol (1992) 2.37

Compartmentalization of a CD4+ T lymphocyte subpopulation in tuberculous pleuritis. J Immunol (1989) 2.27

Response of human natural killer (NK) cells to NK cell stimulatory factor (NKSF): cytolytic activity and proliferation of NK cells are differentially regulated by NKSF. J Exp Med (1992) 2.26

Primary serofibrinous pleural effusion in military personnel. Am Rev Tuberc (1955) 2.16

Interleukin 12 in host defense against microbial pathogens. Proc Natl Acad Sci U S A (1993) 2.08

The recombinant 65-kD heat shock protein of Mycobacterium bovis Bacillus Calmette-Guerin/M. tuberculosis is a target molecule for CD4+ cytotoxic T lymphocytes that lyse human monocytes. J Exp Med (1988) 2.04

Characterization of T cell antigens associated with the cell wall protein-peptidoglycan complex of Mycobacterium tuberculosis. J Immunol (1989) 2.01

IL-12: monoclonal antibodies specific for the 40-kDa subunit block receptor binding and biologic activity on activated human lymphoblasts. J Immunol (1991) 1.78

Prolonged treatment with recombinant interferon gamma induces erythema nodosum leprosum in lepromatous leprosy patients. J Exp Med (1992) 1.63

IFN-gamma-producing ability as a possible marker for the protective T cells against Mycobacterium bovis BCG in mice. J Immunol (1992) 1.45

IL-12 augments antigen-dependent proliferation of activated T lymphocytes. J Immunol (1992) 1.27

Natural killer cell-dependent mycobacteriostatic and mycobactericidal activity in human macrophages. J Immunol (1991) 1.26

Strain- and donor-related differences in the interaction of Mycobacterium avium with human monocytes and its modulation by interferon-gamma. J Infect Dis (1990) 1.17

Evidence for in vivo generation of cytotoxic T cells. PPD-stimulated lymphocytes from tuberculous pleural effusions demonstrate enhanced cytotoxicity with accelerated kinetics of induction. Am Rev Respir Dis (1992) 1.07

Frequency of tuberculin-reactive T-lymphocytes in pleural fluid and blood from patients with tuberculous pleurisy. Chest (1986) 1.01

IL-7 supports the generation of cytotoxic T lymphocytes from thymocytes. Multiple lymphokines required for proliferation and cytotoxicity. J Immunol (1990) 0.98

Analysis of immunologic mechanisms of high natural killer cell activity in tuberculous pleural effusions. Am Rev Respir Dis (1990) 0.92

Articles by these authors

Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. Science (1993) 19.80

Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature (2000) 15.53

Defining protective responses to pathogens: cytokine profiles in leprosy lesions. Science (1991) 8.85

Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. Science (1999) 8.63

Induction of interferon gamma production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers. J Exp Med (1991) 7.52

Interleukin 12 and tumor necrosis factor alpha are costimulators of interferon gamma production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist. Proc Natl Acad Sci U S A (1993) 6.33

IL-12-deficient mice are defective in IFN gamma production and type 1 cytokine responses. Immunity (1996) 6.16

Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones. Science (1991) 6.12

Recombinant interleukin 12 cures mice infected with Leishmania major. J Exp Med (1993) 5.75

Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response. J Exp Med (1993) 5.71

An antimicrobial activity of cytolytic T cells mediated by granulysin. Science (1998) 5.02

Cloning and expression of murine IL-12. J Immunol (1992) 4.92

Varenicline versus transdermal nicotine patch for smoking cessation: results from a randomised open-label trial. Thorax (2008) 4.79

Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction. Proc Natl Acad Sci U S A (1998) 4.67

Induction of direct antimicrobial activity through mammalian toll-like receptors. Science (2001) 4.46

Detection of DNA strand breaks in individual apoptotic cells by the in situ terminal deoxynucleotidyl transferase and nick translation assays. Cancer Res (1993) 4.11

The CD1 system: antigen-presenting molecules for T cell recognition of lipids and glycolipids. Annu Rev Immunol (1999) 4.10

Antitumor and antimetastatic activity of interleukin 12 against murine tumors. J Exp Med (1993) 4.04

Relationship of the manifestations of tuberculosis to CD4 cell counts in patients with human immunodeficiency virus infection. Am Rev Respir Dis (1993) 4.01

Assessing the clinical effectiveness of preventive maneuvers: analytic principles and systematic methods in reviewing evidence and developing clinical practice recommendations. A report by the Canadian Task Force on the Periodic Health Examination. J Clin Epidemiol (1990) 3.88

Local production of tumor necrosis factor and IFN-gamma in tuberculous pleuritis. J Immunol (1990) 3.85

Simultaneous genotyping and species identification using hybridization pattern recognition analysis of generic Mycobacterium DNA arrays. Genome Res (1998) 3.85

The interleukin 12 p40 gene promoter is primed by interferon gamma in monocytic cells. J Exp Med (1996) 3.82

Evidence that the src gene product of Rous sarcoma virus is membrane associated. Virology (1980) 3.71

Methylation of the hypoxanthine phosphoribosyltransferase locus on the human X chromosome: implications for X-chromosome inactivation. Proc Natl Acad Sci U S A (1984) 3.53

Neutralization of IL-12 decreases resistance to Listeria in SCID and C.B-17 mice. Reversal by IFN-gamma. J Immunol (1994) 3.50

Tuberculosis in patients with human immunodeficiency virus infection. N Engl J Med (1999) 3.45

Differential effects of cytolytic T cell subsets on intracellular infection. Science (1997) 3.39

A forespore checkpoint for mother cell gene expression during development in B. subtilis. Cell (1990) 3.28

Altered urinary bladder function in mice lacking the vanilloid receptor TRPV1. Nat Neurosci (2002) 3.28

Structural requirements for glycolipid antigen recognition by CD1b-restricted T cells. Science (1997) 3.23

Proto-oncogene PML controls genes devoted to MHC class I antigen presentation. Nature (1998) 3.22

Cytokine patterns in the pathogenesis of human leishmaniasis. J Clin Invest (1993) 3.15

Natural killer (NK) cell stimulatory factor or IL-12 has differential effects on the proliferation of TCR-alpha beta+, TCR-gamma delta+ T lymphocytes, and NK cells. J Immunol (1992) 3.15

Randomised trial of intravenous immunoglobulin G, intravenous anti-D, and oral prednisone in childhood acute immune thrombocytopenic purpura. Lancet (1994) 3.12

A functional interleukin 12 receptor complex is composed of two beta-type cytokine receptor subunits. Proc Natl Acad Sci U S A (1996) 3.07

Cytokine production at the site of disease in human tuberculosis. Infect Immun (1993) 3.04

Cytokine production induced by Mycobacterium tuberculosis lipoarabinomannan. Relationship to chemical structure. J Immunol (1992) 3.03

Quality of life (QoL) analyses from OPTIMAL (CTONG-0802), a phase III, randomised, open-label study of first-line erlotinib versus chemotherapy in patients with advanced EGFR mutation-positive non-small-cell lung cancer (NSCLC). Ann Oncol (2013) 2.92

Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizations. Nat Med (1999) 2.77

Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response. Eur J Immunol (1996) 2.76

Functions of cytoplasmic fibers in intracellular movements in BHK-21 cells. J Cell Biol (1978) 2.74

Cytokine patterns of immunologically mediated tissue damage. J Immunol (1992) 2.72

Recombinant IL-12 administration induces tumor regression in association with IFN-gamma production. J Immunol (1994) 2.68

Interleukin-12 is essential for a protective Th1 response in mice infected with Cryptococcus neoformans. Infect Immun (1998) 2.60

Mouse interleukin-12 (IL-12) p40 homodimer: a potent IL-12 antagonist. Eur J Immunol (1995) 2.57

T-cell cytokine responses in human infection with Mycobacterium tuberculosis. Infect Immun (1995) 2.57

The p53/p63/p73 family of transcription factors: overlapping and distinct functions. J Cell Sci (2000) 2.55

New approaches for studying and exploiting an old protuberance, the plant trichome. Ann Bot (2004) 2.54

T cell cytokine responses in persons with tuberculosis and human immunodeficiency virus infection. J Clin Invest (1994) 2.51

Bcl-2 potentiates the maximal calcium uptake capacity of neural cell mitochondria. Proc Natl Acad Sci U S A (1996) 2.50

Diversity of DNA fingerprints of Mycobacterium tuberculosis isolates in the United States. J Clin Microbiol (1998) 2.49

The ability of an oligomeric human immunodeficiency virus type 1 (HIV-1) envelope antigen to elicit neutralizing antibodies against primary HIV-1 isolates is improved following partial deletion of the second hypervariable region. J Virol (2001) 2.43

Changes in microfilament organization and surface topogrophy upon transformation of chick embryo fibroblasts with Rous sarcoma virus. Proc Natl Acad Sci U S A (1976) 2.38

Restoration of HIV-specific cell-mediated immune responses by interleukin-12 in vitro. Science (1993) 2.35

Delayed diagnosis of tuberculosis in patients with human immunodeficiency virus infection. Am J Med (1990) 2.35

Studies of X chromosome DNA methylation in normal human cells. Nature (1982) 2.34

Nonpeptide ligands for human gamma delta T cells. Proc Natl Acad Sci U S A (1994) 2.33

Effects of IL-12 on the response and susceptibility to experimental viral infections. J Immunol (1994) 2.31

Phorbol myristate acetate stimulates microtubule and 10-nm filament extension and lysosome redistribution in mouse macrophages. J Cell Biol (1980) 2.31

Phylogenetic analysis of rumen bacteria by comparative sequence analysis of cloned 16S rRNA genes. Anaerobe (1998) 2.31

Interleukin 12 administration induces T helper type 1 cells and accelerates autoimmune diabetes in NOD mice. J Exp Med (1995) 2.29

Enhanced capacity of a widespread strain of Mycobacterium tuberculosis to grow in human macrophages. J Infect Dis (1999) 2.29

Interaction of glycogen synthase kinase 3beta with the DF3/MUC1 carcinoma-associated antigen and beta-catenin. Mol Cell Biol (1998) 2.29

Compartmentalization of a CD4+ T lymphocyte subpopulation in tuberculous pleuritis. J Immunol (1989) 2.27

Response of human natural killer (NK) cells to NK cell stimulatory factor (NKSF): cytolytic activity and proliferation of NK cells are differentially regulated by NKSF. J Exp Med (1992) 2.26

Microbial lipopeptides stimulate dendritic cell maturation via Toll-like receptor 2. J Immunol (2001) 2.24

Effects of interleukin 12 on immune responses and host protection in mice infected with intestinal nematode parasites. J Exp Med (1994) 2.22

In situ demonstration of T lymphocyte subsets in granulomatous inflammation: leprosy, rhinoscleroma and sarcoidosis. Clin Exp Immunol (1983) 2.21

Determinants of increased energy expenditure in HIV-infected women. Am J Clin Nutr (1998) 2.21

Human IL-12 p40 homodimer binds to the IL-12 receptor but does not mediate biologic activity. J Immunol (1995) 2.21

Sphingolipids--the enigmatic lipid class: biochemistry, physiology, and pathophysiology. Toxicol Appl Pharmacol (1997) 2.19

Selective modulation of human natural killer cells in vivo after prolonged infusion of low dose recombinant interleukin 2. J Clin Invest (1993) 2.18

CD1c restricts responses of mycobacteria-specific T cells. Evidence for antigen presentation by a second member of the human CD1 family. J Immunol (1996) 2.13

Recombinant Mycobacterium tuberculosis protein associated with mammalian cell entry. Cell Microbiol (2001) 2.12

IL-12-induced protection against blood-stage Plasmodium chabaudi AS requires IFN-gamma and TNF-alpha and occurs via a nitric oxide-dependent mechanism. J Immunol (1995) 2.12

Effects of IL-12 on helper T cell-dependent immune responses in vivo. J Immunol (1994) 2.11

The mannose receptor delivers lipoglycan antigens to endosomes for presentation to T cells by CD1b molecules. Immunity (1997) 2.07

Plasma very long chain fatty acids in 3,000 peroxisome disease patients and 29,000 controls. Ann Neurol (1999) 2.06

Binding and antigen presentation of ceramide-containing glycolipids by soluble mouse and human CD1d molecules. J Exp Med (1999) 2.06

Assays of cell viability: discrimination of cells dying by apoptosis. Methods Cell Biol (1994) 2.06

The cytokine network in lesional and lesion-free psoriatic skin is characterized by a T-helper type 1 cell-mediated response. J Invest Dermatol (1993) 2.04

Role of pretransplant echocardiographic evaluation in predicting outcomes following liver transplantation. Am J Transplant (2013) 2.04

Characterization of T cell antigens associated with the cell wall protein-peptidoglycan complex of Mycobacterium tuberculosis. J Immunol (1989) 2.01

T lymphocyte subsets in the skin lesions of patients with leprosy. J Am Acad Dermatol (1983) 2.01

Definition of distinct compartments in polarized Madin-Darby canine kidney (MDCK) cells for membrane-volume sorting, polarized sorting and apical recycling. Traffic (2000) 2.00

Immunosuppressive roles for IL-10 and IL-4 in human infection. In vitro modulation of T cell responses in leprosy. J Immunol (1993) 2.00